APA (7th ed.) Citation

Y, K., S, S., S, K., N, H., R, N., H, S., . . . H, O. (2025). Durvalumab induced immune-related agranulocytosis after conversion surgery in a patient with intrahepatic cholangiocarcinoma: A case report. Frontiers in immunology, 16, 1610190. https://doi.org/10.3389/fimmu.2025.1610190

Chicago Style (17th ed.) Citation

Y, Kitamura, et al. "Durvalumab Induced Immune-related Agranulocytosis After Conversion Surgery in a Patient with Intrahepatic Cholangiocarcinoma: A Case Report." Frontiers in Immunology 16 (2025): 1610190. https://doi.org/10.3389/fimmu.2025.1610190.

MLA (9th ed.) Citation

Y, Kitamura, et al. "Durvalumab Induced Immune-related Agranulocytosis After Conversion Surgery in a Patient with Intrahepatic Cholangiocarcinoma: A Case Report." Frontiers in Immunology, vol. 16, 2025, p. 1610190, https://doi.org/10.3389/fimmu.2025.1610190.